Metraipolis › archive › dc_45be996ffa72
Impact of clinical response and treatment tolerability on HRQoL in newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia patients… — Europe PMC PMID:41071292
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41071292
- DOI
- 10.1007/s00277-[numero omesso]-0
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-10T04:26:29.641Z
- SHA-256 of the archived text
ca969fa7b1f3f2db027dbd342b7ad898627d4ba9f9c9d35cd1ecd96d544c5bb8- Stable URL of this page
https://metraipolis.com/documento/dc_45be996ffa72
How to cite
Impact of clinical response and treatment tolerability on HRQoL in newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia patients… — Europe PMC PMID:41071292 — Europe PMC (en), https://europepmc.org/article/MED/41071292 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_45be996ffa72 (Metraipolis archive dc_45be996ffa72, sha256 ca969fa7b1f3f2db027dbd342b7ad898627d4ba9f9c9d35cd1ecd96d544c5bb8)
BibTeX
@misc{dc45be996ffa72,
title = {Impact of clinical response and treatment tolerability on HRQoL in newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia patients… — Europe PMC PMID:41071292},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41071292},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_45be996ffa72; sha256 ca969fa7b1f3f2db027dbd342b7ad898627d4ba9f9c9d35cd1ecd96d544c5bb8},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41071292. Agents can read the archived copy with the MCP tool read_document.